(17.9%) were excluded for the following reasons: entered by sites with Ͻ75% completeness in documentation of medical history (11 288) , missing information on rtPA treatment and reasons for nontreatment (341), missing discharge destination (9769) or left against medical advice (5252), transferred from another hospital (15 489), symptom onset while admitted at another acute-care facility (49 197) or during hospital admission for another cause (in-hospital stroke, 9087), not admitted through the Emergency Department (ED) (35 362), and transferred to another acute-care facility (16 364). Therefore, in total there were 693 418 patients with ischemic stroke or TIA directly admitted through the ED with complete information. Next, we selected patients whose arrival had been documented to within 2 hours of symptom onset (148 068, 21.3%) because these patients should be time-eligible for rtPA therapy based on the recommended door-to-needle time of 60 minutes or less: 93 517 of these patients had a final diagnosis of ischemic stroke and 54 551 had a final diagnosis of TIA. Patients with a final diagnosis of TIA (nϭ54 441), defined as complete resolution of neurologic symptoms within 24 hours without evidence of brain infarction on neuroimaging, 9 were excluded.
When rtPA is not administered, hospital abstractors review the medical record to classify the reasons for nontreatment. Contraindications, warnings, and system reasons (including in-hospital delays) must be specifically documented by the treating healthcare providers in the medical record as the reason for nontreatment; inference on the part of the abstractor is not allowed. The list of acceptable reasons for nontreatment is derived from professional guidelines and the US Food and Drug Administration labeling (see online-only Table I ) and includes a specific checkbox for "mild or rapidly improving stroke." "Mild/improving stroke" was defined in this analysis for patients with a final discharge diagnosis of ischemic stroke who had "mild or rapidly improving stroke" checked as the sole reason for not providing rtPA, with no other reasons checked, and who were documented to have arrived within 2 hours of symptom onset (nϭ29 200). Therefore, these patients likely would have received rtPA had more severe or persistent symptoms been present. We also performed a sensitivity analysis wherein patients with symptoms present on ED arrival but who had a final diagnosis of TIA were reclassified as "mild or rapidly improving" stroke; this analysis was limited to patients admitted from January 2008 onward. The National Institutes of Health Stroke Scale (NIHSS) score was the initial score recorded in the ED.
The primary outcome was discharge destination, analyzed as discharge to home versus discharge to another inpatient facility or death. The proportion capable of independent ambulation at hospital discharge, defined as ambulation without needing another person's assistance (with or without use of a walking aid such as a cane), was analyzed as a secondary outcome. Information on independent ambulation was missing for 2073 of 29 200 (7.1%). Because patients with a final diagnosis of TIA are expected to have relatively benign, short-term outcomes, similar to those of mild/improving stroke, we present outcomes of the 54 551 TIA patients for comparison purposes.
Patient characteristics according to discharge outcome status were compared by the Pearson 2 test for categorical variables and the 2 rank-based group means score statistic (equivalent to the Kruskal-Wallis test) for continuous or ordinal variables. Logistic regression was used to determine the independent predictors of outcome by using generalized estimating equations to account for clustering of patients by hospital. Models were adjusted for all of the patient and hospital characteristics displayed in Table 1 , as well as for calendar time (per year) and the number of years spent in the GWTG-Stroke program, to account for secular trends over time. Data were missing for Ͻ4% of mild/improving stroke patients for all variables except for past medical history (6.7%), NIHSS score (38.1%), and the number of stroke discharges per year at the admitting hospital (14.5%, predominantly because they were admitted to hospitals with Ͻ1 year of participation in the GWTG-Stroke). For the purpose of multivariable modeling, missing data were imputed as follows: age was imputed to the median, categorical variables were imputed to the most common category, and absent past medical history was imputed to "no." Patients with missing data on hospital characteristics were excluded. Because the number with missing NIHSS score was large, yet NIHSS score appeared to be a critical determinant of outcomes, models were run with and without NIHSS score. Because of the large size of the dataset, all variables were included in the final models without elimination of nonsignificant variables; however, only the significant variables are tabulated. Statistical analyses were performed with SAS version 9.2 (SAS Institute, Cary, NC). A probability value of 0.05 was considered significant.
Results
There were 93 517 acute ischemic stroke patients from 1290 hospitals who had a documented time of arrival within 2 hours of symptom onset: 24 292 (26.0%) received IV rtPA, 29 200 (31.2%) did not receive rtPA solely because of mild/improving stroke, 26 891 (28.8%) did not receive rtPA because of other documented reasons, and 13 134 (14.0%) did not receive rtPA and had no reason documented. There was little change from 2003 to 2009 in the proportion with mild/improving stroke as the sole contraindication to rtPA use ( Figure 1 ). The median hospital-specific percentage with mild/improving stroke was 30.4% (interquartile range, 22.6% to 37.4%) across 818 hospitals, excluding 503 hospitals submitting Ͻ25 patients arriving in Ͻ2 hours.
The median age of the patients with mild/improving stroke was 72 years (interquartile range, 62 to 81 years), and 47.1% were women. Compared with those who did receive IV rtPA, patients with mild/improving stroke were more likely to have a history of prior stroke and dyslipidemia and less likely to have a history of atrial fibrillation (online-only Table II ). The NIHSS score was documented in 18 067 of 29 200 (61.9%) of the patients with mild/improving stroke; the median score was 2 (interquartile range, 1 to 5). Characteristics of mild/ improving stroke patients with versus without a documented NIHSS score are shown in online-only Table III . By comparison, the NIHSS score was documented in 20 095 of 24 292 (82.7%) of the patients given rtPA; the median NIHSS score was 12 (interquartile range, 7 to 18; Figure 2 ).
Among the 29 200 patients with mild/improving stroke not treated with rtPA, there were 8272 (28.3%) patients who could not be discharged to home, including 323 (1.1%) who died, 224 (0.8%) who were discharged to hospice, 3133 (10.7%) who were discharged to a skilled nursing facility, and 4592 (15.7%) who were discharged to acute rehabilitation. There were 7732 of 27 127 (28.5%) who could not ambulate independently by the time of hospital discharge, including 1621 (6.0%) who were unable to ambulate and 6111 (22.5%) who required assistance to ambulate. The median length of stay was 3 days (interquartile range, 2 to 5 days). Patients with higher initial NIHSS scores had worse outcomes (PϽ0.001, Table 2 ). By comparison, among 54 551 TIA patients arriving within 2 hours, there were only 4389 (8.0%) who could not be discharged to home, 110 (0.2%) who died in the hospital, and 6448 of 51 408 (12.5%) who could not ambulate independently (all PϽ0.001 compared with mild/improving stroke). In a sensitivity analysis wherein patients with a final diagnosis of TIA but with symptoms present on arrival were reclassified as "mild or improving stroke," the proportion of ischemic stroke patients with mild or rapidly improving stroke increased to 41.9%, and outcomes were somewhat better but still worse than for TIA (online-only Table IV ). The univariate characteristics of patients with mild/improving stroke who were discharged to home are shown in Table 1 . The multivariable-adjusted characteristics of those who were discharged to home are shown in Table 3 . Patients who were discharged to home had lower initial NIHSS scores and were more likely to be younger, male, and white and to not have diabetes, peripheral vascular disease, or hypertension. Patients taking lipid-lowering medicines before admission were more likely to be discharged to home (Table 3) . Covariate estimates were similar when the model was rerun for all patients without including NIHSS score as a covariate, with the exception that the absence of atrial fibrillation, smoking, and previous stroke or TIA were also associated with an increased likelihood of home discharge when not controlling for NIHSS score (online-only Table V) . Additional multivariable-adjusted analyses showed that outcomes for patients with mild/rapidly improving stroke were better than for rtPA-treated patients with mild stroke (defined as an initial NIHSS score of 0 to 5) but worse than for patients with a final diagnosis of TIA (online-only Tables VI and VII ).
Discussion
This study shows that many patients not given IV rtPA because of mild or rapidly improving stroke symptoms had poor hospital discharge outcomes. This is the first large, nationwide study to show that patients who do not receive rtPA because of mild or rapidly improving stroke are still at risk for requiring inpatient care or rehabilitation after hospital discharge. Discharge outcomes were significantly worse than for those with TIA. The initial NIHSS score was a strong predictor of outcome, with a graded relation between higher NIHSS score and a lower likelihood of discharge to home or . National Institutes of Health Stroke Scale (NIHSS) scores in patients who did or did not receive intravenous recombinant tissue-type plasminogen activator (IV rtPA) treatment because of mild or improving ischemic stroke. Most patients given IV rtPA had NIHSS scores Ͼ5 (84.4%), whereas most patients not given IV rtPA because of mild or improving symptoms had NIHSS scores Յ5 (80.1%).
Smith et al
Outcomes of Mild or Improving Stroke Without rtPA 3113 independent ambulation among those with mild or improving ischemic stroke. Other predictors of lower likelihood of discharge to home, based on multivariable-adjusted analysis, were older age, female sex, black race, diabetes, hypertension, and lack of use of lipid-lowering drugs before admission.
The pivotal 1995 National Institute of Neurological Disorders and Stroke rtPA trial excluded patients with specific minor stroke syndromes or rapidly improving symptoms, without giving specific NIHSS thresholds. 10 In this study, there was a relatively similar hospital-specific percentage of patients arriving Ͻ2 hours who were documented to have mild or rapidly improving stroke across Ͼ800 hospitals. Additionally, this study suggests that the operational definition of "mild or rapidly improving stroke" has not substantially changed over time because the frequency was similar from 2003 to 2009, despite large increases in the proportion of patients who were given rtPA. Most patients with mild or rapidly improving stroke had an initial NIHSS score Յ5, whereas most patients treated with rtPA had NIHSS scores Ͼ5. Other factors that probably influence the decision as whether to give rtPA, such as specific features of the neurologic examination and patient preferences, were not measured in this study. Patients with NIHSS scores substantially Ͼ5 or 10 probably had rapid improvement on the neurologic examination; however, this cannot be confirmed in the current study, because only NIHSS scores at the time of initial assessment were recorded. These patients also had worse outcomes, suggesting that rapid improvement may be associated with a higher risk of subsequent deterioration. 3, 4 Mild or rapidly improving stroke was the most common reason for not giving rtPA to time-eligible patients, occurring in 31.2% of ischemic stroke patient who arrived within 2 hours, consistent with findings from previous registries 1, 11 and a population-based study. 2 More patients were not given rtPA because of mild or improving stroke than were actually given rtPA. The proportion of mild or rapidly improving stroke patients may be underestimated because we could not distinguish whether patients with TIA had symptom resolution after the time of rtPA decision and might have been considered for rtPA; our sensitivity analysis suggests that the true proportion of mild or rapidly improving stroke may be as high as 41.9%.
There are some limitations to this study. Hospital participation in GWTG-Stroke is voluntary, and therefore, participating hospitals may not be representative of the entire US hospital population, although a large number of both community and academic hospitals are included. NIHSS information was missing for many participants, reflecting its incomplete use in routine medical practice. Information on postdischarge outcome or global disability was unavailable. Discharge to home is considered an important outcome for patients, however, and the number of days spent at home within the first 90 days after stroke has been shown to correlate well with disability status. 12 A study of postdischarge 90-day outcomes in patients not given rtPA because of mild or rapidly improving stroke symptoms showed that disabling stroke symptoms (modified Rankin scores Ն2) were present in 24.7%, 4 suggesting that many patients who cannot be discharged to home or who are not ambulating independently at discharge may have residual permanent disability. Discharge to home also depends on factors unrelated to stroke severity, such as social support, prestroke function, local practice patterns, and insurance status, which were not measured in this study. Information on prestroke Stroke patients with NIHSSϭ0 had either imaging evidence of infarction or stroke symptoms not quantifiable on the NIHSS. Outcomes were strongly associated with initial NIHSS score (PϽ0.001).
NIHSS indicates National Institutes of Health Stroke Scale. place of residence was unavailable in this study; therefore, some of the patients not discharged to home may have been residing in another healthcare facility, such as a nursing home, before admission and could not have been discharged to home regardless of their stroke outcomes. Finally, the risk of neurologic deterioration in mild or rapidly improving stroke has been associated with the presence of vascular occlusion 3, 4, 6 or initial severe symptoms followed by dramatic improvement 3, 4 ; however, information on these characteristics is unavailable in GWTG-Stroke. During the study period, mild stroke was not discriminated from rapidly improving stroke. Further prospective studies with serial assessments of stroke severity at the scene and in the ED will be needed to determine the relation between timing and the degree of symptom improvement and the risk of subsequent deterioration.
These data suggest that physicians should not assume that patients with initially mild or rapidly improving ischemic stroke symptoms are at low risk for requiring inpatient care or rehabilitation after hospital discharge. The reasons for poor outcomes cannot be determined from this study but could include persistent stroke-related deficits, recurrent stroke, or medical complications of stroke. A re-examination of the criteria for excluding patients from rtPA because of mild or rapidly improving symptoms may be warranted, pending further studies. Previous subgroup analyses of the 1995 National Institute of Neurological Disorders and Stroke study 10 and the ECASS III study 13 suggest that rtPA is similarly effective in milder strokes as in more severe strokes. A randomized, controlled trial of rtPA for treatment of mild or rapidly improving stroke should be considered. 
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S1). Categories of Reasons for Non-treatment with IV rt-PA
Contraindications:
-SBP > 185 or DBP > 110 mmHg despite treatment -Seizure at onset -Recent surgery/trauma (<15 days) -Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.) -History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor -Active internal bleeding (<22 days) -Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis -Suspicion of subarachnoid hemorrhage -CT findings (ICH, SAH, or major infarct signs) Warnings:
-Advanced age -Care-team unable to determine eligibility -Glucose < 50 or > 400 mg/dl -Increased risk of bleeding due to comorbid conditions (see coding instructions) -IV or IA rt-PA given at outside hospital -Left heart thrombus -Life expectancy < 1 year or severe co-morbid illness or CMO on admission -Pregnancy -Pt./Family refused -Rapid improvement or stroke severity too mild -Stroke severity -Too severe (e.g., NIHSS >22) Hospital or other related factors:
-Delay in Stroke diagnosis -Inhospital Time Delay -No IV access -Other Supplement Table 1 Legend
List of contraindications, warnings, and system reasons for not administering rt-PA that can be checked in the Get With The Guidelines-Stroke case report form. Chart abstractors are instructed that the reason for not giving rt-PA must be specifically documented in the medical record in order to be abstracted; inference on the part of the abstractor is not allowed. These categories were derived from professional guidelines 1, 2 and the approved use labeling for alteplase by the U.S. Food and Drug Administration. 3 
Supplemental
Length of Stay
Median (interquartile range) 3 (2-5) 3 (2-4) 2 (1-3)
Ambulation
Not independent 26.7 21.3 11.3
Table Legend
In primary analyses we excluded patients with a final diagnosis of TIA, even though some patients may have had neurological symptoms at the time of tPA decision and could have been clinically treated as mild or improving stroke. To determine the impact of including TIA patients with neurological symptoms at the time of ED arrival, we performed a sensitivity analysis limited to the 63,860 patients included since January 2008, when information on the presence or absence of symptoms on ED arrival was collected. Among 24,063 patients with final diagnosis of TIA, 6,500 (27.0%) had symptoms present on ED arrival and were reclassified as mild or improving stroke in this sensitivity analysis. In the sensitivity analysis the prevalence of mild or improving stroke among all ischemic stroke patients was 41.9% (19,412/46,297) when using the revised definition, compared to 32.4% (12,912/39,797) when using the primary definition. Because we do not have information on when symptoms resolved in patients with symptoms on ED arrival but final diagnosis of TIA, we are unable to determine how many of these patients had symptom resolution prior to the time of tPA decision and would have been clinically treated as TIA. Therefore the true proportion of mild or improving stroke, as ascertained at the time of tPA decision, is somewhere between 32.4% and 41.9%.
Outcomes were somewhat better when using the revised sensitivity definition of mild or improving stroke vs. the primary definition; however, outcomes for mild or rapidly improving stroke patients were significantly worse than TIA (p<0.001 for all outcomes) by either definition. There were 29,200 patients with mild or rapidly improving stroke and 3,139 patients with admission NIHSS 0-5 who were treated with rt-PA. Adjusted outcomes were better in the patients not treated with rt-PA because of mild or rapidly improving stroke, compared to rt-PA-treated patients with mild stroke (NIHSS 0-5). Caution should be exercised in the interpretation of these results, however. Because rt-PA was used based on physician preference and not randomly assigned, it is possible that the observed apparent deleterious effect of rt-PA may represent residual confounding by poor prognostic features that might have influenced the decision whether to give rt-PA or not. Patients not treated with rt-PA because of mild or improving stroke had an increased risk of death and decreased odds of discharge to home or ambulating independently at discharge, compared to patients with TIA.
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